Microvascular invasion of hepatocellular carcinoma predicts microvascular invasion of its recurrence: potential implications for salvage liver transplantation?

Journal Information

Full Title: Hepatobiliary Surg Nutr

Abbreviation: Hepatobiliary Surg Nutr

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Nutrition & Dietetics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-21-346/coif). HL serves as an unpaid editorial board member of Hepatobiliary Surgery and Nutrition. JUM participated in advisory boards for Bayer, Eisai, AstraZeneca, Roche. PRG receives consulting fees from Bayer, Boston Scientific, AstraZeneca, Adaptimmune, BMS, Eisai, MSD, Sirtex, Lilly, Roche, Guerbet, Ipsen; and payment or honoraria from Bayer Adaptimmune, Sirtex, Lilly, Roche, Ipsen. The other authors have no conflicts of interest to declare."

Evidence found in paper:

"Funding: None."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025